Nancy A. Rigotti, MD, of the Tobacco Research and Treatment Center at Massachusetts General Hospital and Harvard in Boston, agreed in aneditorial accompanying the NEJM paper. However, getting the drug to the U.S. market could be a challenge, Rigotti told MedPage Today. The manufacturer in Bulgaria never saw a market for the drug in the U.S. and so never tried for approval, she explained. "We're sort of stuck here," she said in an interview.

With the start of the financial year the management of Sopharma AD parts with the company’s Commercial Director. Vladimir Stoychev joined the team of Sopharma AD in September 2001 as a warehouse manager for export goods. Later he was transferred to the position of Head of Kazahstan office. His good work lead eventually to his promotion to Commercial Director of Sopharma AD in 2007. The management team of the company wishes Mr. Stoychev success in his new professional endavoures. The Executive Director of the company will temporarily be responsible for the export markets.

Sopharma AD (the “Company”) notifies that in connection with the Easter Holiday the results for April 2013 will be published on 10 May 2013.

We would like to notify, that Sopharma AD received  the following opinion from Momina krepost AD:

On 27 March 2013, we received a notification pursuant to art. 151, par. 3 of POSA, accompanied by a tender offer under art. 149, par. 6 of POSA from Sopharma AD for purchasing of the shares of the remaining shareholders of Momina Krepost AD.

In accordance with art. 151, par. 5 of POSA and within the statutory period we present a motivated opinion regarding the tender offer.

І. Conditions of the tender offer

We would like to notify that on 18 May 2012 (Friday) Sopharma AD will conduct a regular Annual Meeting with Investors, which will take place in the Conference center of Sopharma Business Towers. We kindly request that all interested parties notify us not later than May 11, 2012 by e-mail ir@sopharma.bg or by telephone +3592 8134 319 in order to receive their registration forms. Places is limited.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that Sopharma AD will commence the paying of dividends for 2012 on 29 July 2013 in accordance with a List of Entitled Persons as at 5 July 2013, prepared by the Central Depository.

The Board of Directors of Sopharma notifies that on its meeting carried out on June 16, 2014 it took a decision to initiate a procedure for merging Bulgarian Rose – Sevtopolis AD, VAT number 123007916 based in the city of Kazanlak on 110, “23d pehoten polk” Blvd. into Sopharma AD, under the regulation of the Commercial Code and art. 122 and the following of the Law on Public Offering of Securities and chooses “Elana Trading” AD VAT number 831470130 , based on 4, Kuzman Shapkarev Str. for a consultant in relation to the merger.

Sopharma AD (the “Company”) hereby notifies all shareholders of the Company, that the Annual General Meeting, convened by the Board of Directors for 20 June 2014 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30. All shareholders of the company are invited to participate at the General Meeting in person or by proxy.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that Sopharma AD will commence the paying of dividends for 2011 on 31 August 2012 in accordance with a List of Entitled Persons as at 13 July 2012, prepared by the Central Depository.

Fifteen students will participate in the Eco-educational Camp "With the Smell of Resin" for children from poor families in the Rakitovo region. The camp will be accomplished by a team of the Baikaria Association. Since the interest in this camp is great, children will be selected not by social principle alone (brought up by relatives or by a single parent, or in a family of unemployed). Candidates will write an essay on an environmental topic, and the competition has been organised with the assistance of the school in Rakitovo.